Advertisement

Here's What Investors Need to Know About COVID Vaccines and Allergic Reactions

Similar reports emerged after Moderna's (NASDAQ: MRNA) vaccine rolled out. In this Motley Fool Live video recorded on Dec. 23, 2020, Healthcare and Cannabis Bureau Chief Corinne Cardina and Fool.com writer Keith Speights talk about what investors need to know about COVID vaccines and these allergic reactions.